ISPE
JULY 10, 2023
The team, composed of end user pharmaceutical companies, equipment vendors, and academics, set out to establish equipment requirements, identify opportunities for harmonization and flexible integration, and suggest enhancements to current equipment. Meet Heather Patterson, Human Resources Manager.
ISPE
MARCH 16, 2023
By removing the need for manual handling and reducing the risk of contamination, pharmaceutical manufacturers can produce products that meet the highest standards of quality. Automated systems offer a range of options for pharmaceutical companies. This also results in significant cost savings and increased efficiency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BuzzRx
JANUARY 27, 2023
Off-label drugs are approved drugs prescribed for an indication, a patient population, a dose, or a dosage form that has not been approved through the usual FDA approval process. Given in a dosage form that is not FDA-approved. We will also list some common examples of off-label drug use. What is off-label drug use?
Pharmaceutical Technology
JUNE 15, 2023
But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. With this added knowledge, researchers can design more efficient and effective clinical trials while identifying the most suitable patient populations, treatment regimens and dosages.
Viseven
SEPTEMBER 14, 2023
Hidden expenses can pile up, spiraling out of control due to many reasons related to supplier performance: the lack of appropriate documentation, storage, wrong dosage forms, and the list goes on. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety.
Pharmaceutical Technology
JULY 18, 2022
With the ever-rising costs of bringing a drug to market, pharmaceutical companies are increasingly looking at how they can improve the efficiency of their entire product development and drug commercialisation process. This important stage of the drug’s lifecycle can be very time-consuming for pharmaceutical companies.
ISPE
JULY 5, 2023
For example, one pharmaceutical company that switched to CM reported a 50% reduction in operating costs, a 33% reduction in waste, an 80% reduction in manufacturing and testing cycle time, and a 66% reduction in time from testing to release. End-to-end continuous processes flow from starting materials to finished dosage forms.
Expert insights. Personalized for you.
52 
Let's personalize your content